The first pitch channel. You can watch the pitches and discussion from the following Teams!
|
13:45-14:00 |
Pitch creativity SenseNS |
|
14:00-14:15 |
Pitch creativity SenseGlasgow |
|
14:15-14:30 |
Pitch creativity Sensing Barcelona |
|
14:30-14:45 |
Pitch creativity Minerva |
|
14:45-15:00 |
Pitch creativity UppSense |
|
15:00-15:15 |
Pitch creativity T.E.S.T 2020 |
The second pitch channel. You can watch the pitches and discussion from the following Teams!
|
13:45-14:00 |
Pitch translation potential Helvet'Sens |
|
14:00-14:15 |
Pitch translation potential UppSense |
|
14:15-14:30 |
Pitch translation potential AUSense |
|
14:30-14:45 |
Pitch translation potential SenseNC |
|
14:45-15:00 |
Pitch translation potential TruSense |
|
15:00-15:15 |
Pitch translation potential LxUs |
The third pitch channel. You can watch the pitches and discussion from the following Teams!
|
13:45-14:00 |
Pitch creativity TruSense |
|
14:00-14:15 |
Pitch creativity UT+ |
|
14:15-14:30 |
Pitch creativity EpiSense |
|
14:30-14:45 |
Pitch creativity Helvet'Sens |
|
14:45-15:00 |
Pitch creativity BiosensUM |
|
15:00-15:15 |
Pitch creativity AUSense |
The fourth pitch channel. You can watch the pitches and discussion from the following Teams!
|
13:45-14:00 |
Pitch translation potential Minerva |
|
14:00-14:15 |
Pitch translation potential BiosensUM |
|
14:15-14:30 |
Pitch translation potential T.E.S.T. 2020 |
|
14:30-14:45 |
Pitch translation potential UT+ |
|
14:45-15:00 |
Pitch translation potential Sensing Barcelona |
|
15:00-15:15 |
Pitch translation potential DeTectUs |
The fifth pitch channel. You can watch the pitches and discussion from the following Teams!
|
13:45-14:00 |
Pitch creativity LxUs |
|
14:00-14:15 |
Pitch creativity DeTectUs |
|
14:15-14:30 |
Pitch creativity AixSense |
|
14:30-14:45 |
Pitch translation potential SenseGlasgow |
|
14:45-15:00 |
Pitch translation potential EpiSense |
|
15:00-15:15 |
Pitch translation potential AixSense |
This Key-Note will be presented by Alain van Gool, professor Personalized Healthcare and he heads the Translational Metabolic Laboratory at the Radboud university medical center, with a strong passion in the application of biomarkers in translational medicine and personalized healthcare. His professional background since 1991 is a mix of academia, pharmaceutical industry, applied research institutes and university medical centers.
He has been leading technology-based biomarker laboratories, cross-functional expert teams, therapeutic project teams and public-private consortia, many of which were focused on the discovery, development and implementation of translational biomarkers in a variety of therapeutic areas. His technical expertise resides most strongly in molecular profiling (various Omics approaches), analytical biomarker development, and applications in translational scientific research.
Innovations in Personalized Healthcare
The key-note will be about the fact that we have reached a fantastic period in biomedical science. Exponential developments in molecular technologies such as next generation sequencing and mass spectrometry have enabled us to obtain increasing insights in the molecular components of human biology and their interactions. Novel personalized diagnostics and high precision therapies that modulate selected disease mechanisms are now driving the new paradigm of precision medicine.
The parallel strong developments in digital biomarker platforms like wearables and apps further drive the personalized aspect of health management, even towards prevention of un-health. Collectively, we now aim to translate interdisciplinary research to knowledge, understanding and actionable decisions for people to maintain and/or improve their health.
However, while embarking on the road towards precision medicine, we are rediscovering that human physiology is a highly complex system and that we need multiple viewing angles to begin to understand the complexity, identify its key nodes and define optimal personalized therapies. To innovate to the next level, we need to be fully aware of the many lessons learned thus far and use these to translate novel molecular technologies to clinical practice. Promising developments will be highlighted.
The plenary closing of the SensUs Event.
During the Closing, we will award the Teams with the best technical ideas, business model and the most votes their awards. We will also announce the runners-up. The theme of next year will be revealed in addition to the upcoming Events.